Retatrutide is now being further evaluated in large-scale phase 3 clinical trials under the TRIUMPH program, which includes multiple studies assessing its effects in obesity, overweight with comorbidities, and type 2 diabetes
In 2025, the RAND American Life Panel showed that women aged 3049 were more than twice as likely as men of a similar age to report current or past use of GLP-1s
This comprehensive formula supports joint, skin, muscle, gut, and metabolic health while delivering key nutrients like vitamin C, folate, calcium, magnesium, and iron
2-11 Modest reductions in weight of 5 to 10% can produce clinically significant improvements in CVD risk factors
Yet, there are still no approved options that directly reverse advanced fibrosis or cirrhosis